Eczema Free Forever™ Eczema Free Forever™

Tag Archives: 2017

talkhealth: Winners of BHBIA 2017 BOBI award!

Posted on by

Winners of Excellence in Data Collection

Last week talkhealth had the honour of winning one of the BHBIA’s (British Healthcare Business Intelligence Association) 2017 BOBI awards. The BOBI Awards (Best of Business Intelligence) are the first and only healthcare-specific business intelligence awards scheme in the UK, giving professionals in our industry an opportunity to gain peer recognition for excellence in business intelligence, market research (including fieldwork) and sales research/analytics. talkhealth were the winners of the Excellence in Data Collection and Fieldwork award sponsored by SERMO.

 

Award sponsored by SERMO and presented by Eva Laparra

We would like to extend our thanks to the BHBIA and the Judging Panel for selecting us as one of the2017 winners. We would also like to thank you, our members, for your support over the years. We will continue to offer trusted information and support to help you better manage your health, and very much appreciate your help with our surveys and research, all of which enables us to provide you with exactly what you need.

talkhealth Blog

Looking Forward to 2017

Posted on by

With eczema and food allergies

Well that was an interesting year, wasn’t it? Like many of you we’re glad to be through it mostly, and looking forward to a happy and healthy 2017.

However, there has been some good news this last year for families affected by eczema and food allergies, so I thought it would be nice to do a quick round-up of the big ones, in the interests of celebration and optimism.

Eczema treatments

In the field of eczema, we have some exciting new treatments in the pipeline, that we hope might become available and be good for some of us over the coming years; along with some very interesting research projects:

Research

Scarring

And for anyone with severe scarring, this looks amazing.  Perhaps it’s not something that will ever be used in our arena, but the development itself, in which someone’s own skin’s stem cells are used to rebuild skin fills me with hope.

Food allergies

And on the food allergies side, we have new research too:

It feels like an exciting time with real breakthroughs being made in both the field of eczema treatment and in the food allergy arena, and we’re hoping 2017 is as fruitful.

As ever, we hope to be picking up on the big stories throughout the coming year and keeping you up to date with all the new changes in research and development on eczema and food allergies.  Please do share your stories and experiences with us too.

In the meantime, I hope you have a happy and scratch-free 2017.

 

Everything For Eczema

Anaphylaxis Campaign – Orange Wig Day Friday 19 May 2017

Posted on by

Living with severe allergies and being at risk of anaphylaxis (a severe and potentially fatal allergic reaction) seriously affects the lives of those at risk. There is currently no cure or treatment to prevent anaphylaxis – instead people must learn to manage their condition and carry adrenaline.

The Anaphylaxis Campaign is the only UK wide charity focused on supporting those at risk of severe allergies. We have been providing information and support to patients and their families for over 21 years.

They do not receive any government funding or grants and rely on support from people like you to create a safer and better life for those living with the fear of anaphylactic shock.

So, get ready to show your support to those living with severe allergies by donning your orange wig on Friday 19 May 2017 for Orange Wig Day

To sign up to fundraise for Orange Wig Day as an individual, school or business or to order your orange wig see the Anaphylaxis Campaign website here.

talkhealth Blog

WellChild Awards 2017:  Nominations open for inspirational children, young people and carers

Posted on by

More than 100,000 children and young people are living with serious illness or exceptional health needs across the UK. Many spend months, even years in hospital simply because there is no support enabling them to leave.

Do you know a seriously ill child or young person who is defying the odds? Or a health professional that goes above and beyond for the children in their care? This is your chance to recognise their achievements and give them a night they will never forget. 

National children’s charity, WellChild has opened nominations for the 2017 WellChild Awards, in association with GSK. This prestigious annual event, regularly attended by WellChild Patron Prince Harry celebrates the inspirational qualities of the UK’s seriously ill children and young people and the dedication of those who go that extra mile to make a real difference to their lives – from doctors and nurses, to brothers, sisters and friends.  

At last year’s star-studded ceremony at the Dorchester in London, each winner had the chance to chat with Prince Harry and mingle with a room full of their favourite celebrities including Sir Rod Stewart, Gaby Roslin, Ashley Banjo and Perri Kiely from Diversity, TV presenter Katie Piper and Olympic gold medal winner Sam Quek. 

So if you know someone who deserves special recognition then nominate them for a WellChild Award by visiting www.wellchild.org.uk/wellchild-awards-2017/ or contacting the charity on 01242 530007 to request a nomination form.

The closing date for all entries is Monday, 1st May 2017.

talkhealth Blog

Quit smoking while pregnancy – No Smoking Day 8 March 2017

Posted on by

March 8th 2017 is national no smoking day and for the estimated 15.8 % of the UK population who regularly light up this is the day you are encouraged to kick the habit.

Parents to be are one particular group who should consider quitting smoking for the sake of their own health and that of their unborn child.

Currently statistics report that just over 10% of babies in the UK are born to mothers who smoke. Whilst this figure is still high, this is a reduction from the previous year of 11% and down from 15% a decade ago.

While this is good news there is no doubt that smoking in pregnancy is harmful to both the mother and the baby; even passive smoking is bad.

Cigarettes contains around 4,000 different chemicals which go into your lungs when you smoke. The types of chemicals found in cigarettes include; Acetone (found in nail polish remover), Ammonia  (a common household cleaner), Cadmium (active component in battery acid), Carbon Monoxide (released in car exhaust fumes), Formaldehyde (embalming fluid) and of course nicotine.

Once they’ve gone into your lungs, the nicotine, poisons and carbon monoxide cross the placenta to the baby. This can cause issues such as:

  • complications during labour
  • increased risk of miscarriage, still-birth and sudden unexpected death in infancy (sometimes referred to as SIDS or cot death)
  • premature birth
  • facial abnormalities at birth such as cleft lip
  • low birth-weight
  • behavioural problems such as ADHD (Attention Deficit Hyperactivity Disorder)
  • performing poorly at school

There is no safe level of smoking. There is no evidence that cutting down is beneficial, and so the only option is to stop smoking completely.

Stopping smoking is hard for most people and you shouldn’t be embarrassed to seek help to quit. If you are thinking of stopping or have recently stopped smoking and are pregnant speak to your midwife who may refer you to a stop smoking adviser. You can also talk to your GP or go to the NHS website – https://www.nhs.uk/smokefree – Support can be offered over the phone, via apps, emails or face to face.

You may be offered Nicotine Replacement Therapy (NRT) in the form of patches, chewing gum, mouth sprays etc. According to the Royal College of Obstetricians and Gynaecologists’, it is safe to use NRT in pregnancy. This is because NRT does not contain poisons such as tar and carbon monoxide, but does provide some nicotine to help manage withdrawal cravings once you have stopped smoking.

If your partner smokes then you need to encourage them to quit too as it will increase your chances of giving up too.

Quitting smoking will also save significant amounts of money. A 10 a day habit will save you around £2190  as well as ensuring you provide the best start in life to your baby.

talkhealth Blog

Looking Forward to 2017

Posted on by

With eczema and food allergies

Well that was an interesting year, wasn’t it? Like many of you we’re glad to be through it mostly, and looking forward to a happy and healthy 2017.

However, there has been some good news this last year for families affected by eczema and food allergies, so I thought it would be nice to do a quick round-up of the big ones, in the interests of celebration and optimism.

Eczema treatments

In the field of eczema, we have some exciting new treatments in the pipeline, that we hope might become available and be good for some of us over the coming years; along with some very interesting research projects:

Research

Scarring

And for anyone with severe scarring, this looks amazing.  Perhaps it’s not something that will ever be used in our arena, but the development itself, in which someone’s own skin’s stem cells are used to rebuild skin fills me with hope.

Food allergies

And on the food allergies side, we have new research too:

It feels like an exciting time with real breakthroughs being made in both the field of eczema treatment and in the food allergy arena, and we’re hoping 2017 is as fruitful.

As ever, we hope to be picking up on the big stories throughout the coming year and keeping you up to date with all the new changes in research and development on eczema and food allergies.  Please do share your stories and experiences with us too.

In the meantime, I hope you have a happy and scratch-free 2017.

 

Everything For Eczema

2017 New Year Resolutions… taking control!

Posted on by

This year I’m going to get my focus back and find my caring side. For too long I’ve been in denial, that I already cut out so many things so why shouldn’t I indulge in freefrom processed foods as a treat and enjoy alcohol when I feel like it. I don’t need to watch my weight and I already cut out dairy, wheat, soya, nuts and celery and tomato for health reasons so why limit myself further?

Well I’ve come to a kind of light bulb moment. I have to do this. For myself. For my sanity. Because I KNOW that the above things irritate my skin. I haven’t wanted to face the undeniable truth that my skin will always be dry, parched, thickened, itchy and damaged if I continue to ignore all the signs. But there you have it. I’m going to do this. I may not succeed 100% first time, I may have setbacks and slip-ups, but I have a plan and I am going to stick to it.

newyearnewme

  1. Cut out ALL processed foods for one month

    2. So my first new year resolution is to see if, just for a month, I can completely cut out processed foods. I don’t know why these foods irritate my skin but the do. Especially gluten fee bread. I can’t work out whether it’s stabilisers, emulsifiers, preservatives or additives but something has a very bad effect on my skin.

    I’ve blogged about this a lot, and there are a few cheat products that are processed but that I let sneak through the net e.g. rice cakes, oat cakes, plant milks, humous etc. Products that are made from a few very simple ingredients are allowed.

    And it’s day one of this regime and I already feel so much calmer. My skin is only slightly itching. If I can do it for a day, I can do it for a week. If I can do it for a week I can do it for a month. And if it helps it will soon become habit.

  2. Cut down on alcohol consumption

    3. I know that alcohol makes my skin dehydrated. Most alcohol also makes my face flush, a side effect of using Protopic on my skin. But I enjoy a drink. My only vice, but I know that often I drink too much, especially red wine. I enjoy drinking it. I have so few vices so I’ve been telling myself, ‘You can’t be good all the time and avoid EVERYTHING bad can you?’ But I would enjoy having clear skin, sleeping well, itching less and not having such dry skin far more than drinking wine.

    It’s my birthday this month so I’m being realistic. I am not setting myself a target I cannot keep, setting myself up to fail miserably at the first hurdle. I will enjoy a drink on my birthday and I probably will have some at weekends, But I AM going to drink less.

    And whilst it may seen horribly unfair, if you want better skin you need to start learning what’s important, because little slip ups on a regular basis will prevent you from EVER getting the skin you dream of.

    I just need to be strong, because all too often I intend to drink soft drinks but find myself almost pushed, persuaded and lured back to the booze by what I call the ‘beer bullies’. If I ask for a soft drink, just give me one please. I mean it. It shouldn’t matter what someone drinks so please, respect my wishes and help me with this please everyone 🙂

  3. Get my skin out and proud

    4. I have also decided that if my skin is bad I’m not going to be ashamed of it any more. It’s my skin, it’s where I live, it’s what holds my fragile body together. I don’t have another one. Just this one. So if you don’t like my skin, please look the other way and don’t comment. I am also going to be kinder to my skin, be prepared and moisturise more. I am going to experiment with natural skincare products to see if I can find things that soothe and heal my skin better than the industrial Epaderm I rely on. I’m going to be kinder to my skin.

  4. Practise Mindfulness

    5. This is something I’ve been thinking about for a while and I have looked into it, in a very blase kind of way so far. But if stress and depression can affect my skin in a very negative way, can the opposite thinking have a positive effect? I’m hoping it will because we all know how powerful the mind is. For instance, can I choose not to scratch? Can I use the power of positive thinking to reinforce my mind to ignore the itch impulse? Can learning mindfulness bring me an inner peace that will help me to cope with stress and avoid getting uptight, worrying so much and over thinking?

  5. Exercise more and get to a healthier place

    6. I have booked myself onto a yoga course in my lunch breaks for 12 weeks at a local gym near where I work, but this is just the beginning of my plan. I want to try to do yoga twice a week, start running at least twice a week and keep up my regular walking with my good friend at work. Having a healthy body is so important for healthy skin. It’s almost as if the sweating helps to purge the body of impurities and irritants. I do get a lot of pain when I sweat if my eczema is bad but I just have to work through this, get into the shower quick and it will get easier. I am hoping this will also help my asthma, which has also been awful lately; a combination of dust, warm houses, central heating and the wrong foods have all contributed, as well as a lingering throat infection that went to my chest. I think that is finally almost gone (famoust last words).

    I’ve also just done my first pre-work 5k run on my first day back in the office. Start as you mean to go on… hopefully this will be a weekly run so I’ll be so fit you won’t see me for dust. Except I’m also allergic to dust 🙂

I am also planning an blog overhaul to watch out for the new look What allergy.com very soon. I have already got my blogging mojo back so look out for more regular blogging. I have so missed this… it’s been too long but I’m back on this now.

I also have a few books planned for you so watch out for these too once the new blog is in place.

What are your New Year Resolutions?

talkhealth Blog

Aarkstore Enterprise – Atopic Dermatitis – Pipeline Assessment and Market Forecasts to 2017

Posted on by

Aarkstore announce a new report  “Atopic Dermatitis – Pipeline Assessment and Market Forecasts to 2017 ” through its vast collection of market research report.

Summary

“Atopic Dermatitis – Pipeline Assessment and Market Forecasts to 2017”. The report is an essential source of information and analysis on the global Atopic Dermatitis therapeutics market. The report identifies the key trends shaping and driving the global Atopic Dermatitis therapeutics market. The report also provides insights into the competitive landscape and the emerging players expected to significantly alter the positions of the existing market leaders. Most importantly, the report provides valuable insights into the pipeline products within the global Atopic Dermatitis sector.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

GlobalData has estimated the global atopic dermatitis therapeutics market to be valued at $ 728m in 2009. It is expected to grow to $ 942m at a Compound Annual Growth Rate (CAGR) of 3.3% by 2017. This growth is primarily attributed to an increase in competition among existing products and the presence of a strong pipeline with more emerging therapies. Globally, the US remains the largest market for atopic dermatitis therapeutics, and was valued at $ 415m in 2009.However, with most of the demand expected to come from the developed economies, the center of global atopic dermatitis therapeutics market activity is potentially due for a paradigm shift.

Scope

The scope of the report includes:
– Annualized global Atopic Dermatitis therapeutics market revenue data from 2001 to 2009, forecast for eight years to 2017.
– Geographies covered in this report include the United States (US), the United Kingdom (UK), Italy, Spain, Germany, France and Japan.
– Pipeline analysis data providing a split across different phases, mechanisms of action being developed and emerging trends. The key classes of mechanism of action include Anti-inflammatory, Corticosteroid, Interleukin Inhibitor, Antimicrobial, Immunomodulators, Protease Inhibitor, Nuclear Factor-Kappa B (NF-kB) inhibitor, Selective cannabinoid 2 receptor agonist, T-cell inhibitor, Vitamin D derivative, Cytokine Modulator, NO synthase inhibitor, Kinase Inhibitor,Calcineurin Inhibitor, Anti-pruritic, Histamine H1 antagonist, Chymase inhibitor, Anti-Neoplastic, TNF Antagonist, Non-steroid, Anti-itching, Vaccine, Combination, H4R antagonist, Serine proteinase inhibitor, RAFT modulator, Neurokinin 1 (NK1) receptor agonists, Vascular adhesion protein-1 (VAP-1) inhibitor, non-comedogenic, Fibroblast Growth Factor (FGF) inhibitor, TSLP interaction Inhibitor, Phosphodiesterase 4 (PDE4) Inhibitor, NGF receptor blocker and Glucocorticoid receptor agonist.
– Analysis of the current and future market competition in the global Atopic Dermatitis therapeutics market. The key future market players covered are Provectus Pharmaceuticals, AnGes MG Inc., Creabilis Therapeutics, Asubio Pharma, Almirall, Anacor Pharma, MIKA Pharma GmbH, Shionogi USA, Inc. and Serentis Ltd
– Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
– Key topics covered include a strategic competitor assessment, a market characterization, the unmet needs and the implications for the Atopic Dermatitis market.

Reasons to buy

The report will enhance your decision making capability. It will allow you to:
– Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipelines.
– Develop business strategies by understanding the trends shaping and driving the global Atopic Dermatitis therapeutics market.
– Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to affect the global Atopic Dermatitis therapeutics market in the future.
– Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
– Identify the emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
– Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investments and strategic partnerships.
– What’s the next big thing in the global Atopic Dermatitis therapeutics market landscape? Identify, understand and capitalize.

For more information, please visit:
http://www.aarkstore.com/reports/Atopic-Dermatitis-Pipeline-Assessment-and-Market-Forecasts-to-2017-65421.html
Or email us at press@aarkstore.com or call +919272852585

Aarkstore Enterprise specialize in providing online market business information on market research reports, books, magazines, conference booking at competitive prices, and strive to provide excellent and innovative service to our customers. We are built on the premise that reading is valuable, capable of stirring emotions and firing the imagination. Whether your looking for new product trends or competitive analysis of a new or existing market, Aarkstore Enterprise has the best resource.

Atopic Dermatitis – Pipeline Assessment And Market Forecasts To 2017

Posted on by

GlobalData estimated the global atopic dermatitis therapeutics market to be valued at $ 728m in 2009. It is expected to grow to $ 942m at a Compound Annual Growth Rate (CAGR) of 3.3% by 2017. This growth is primarily attributed to an increase in competition among existing products and the presence of a strong pipeline with more emerging therapies. Globally, the US remains the largest market for atopic dermatitis therapeutics, and was valued at $ 415m in 2009. However, with most of the demand expected to come from developed economies, the center of global atopic dermatitis therapeutics market activity is potentially due for a paradigm shift.
For further details, please click or add the below link to your browser:

http://www.globaldata.com/reportstore/Report.aspx?ID=Atopic-Dermatitis-Drug-Pipeline-Analysis-and-Market-Forecasts-to-2016&ReportType=Industry_Report&coreindustry=Industry_Report&Title=Pharmaceuticals_and_Healthcare

In 2009, there were approximately 35 million cases of atopic dermatitis reported within the seven geographies (the US, the UK, Germany, France, Spain, Italy and Japan). This equated to a prevalence of approximately 5%. GlobalData estimates that the number of atopic dermatitis patients is forecast to increase to about 42 million by 2017, representing an increase in prevalence. Some of the factors associated with an increased risk of atopic dermatitis include small family size, higher socioeconomic and educational levels regardless of ethnicity, movement from a rural to an urban environment, and an increased use of antibiotics. Research has indicated that there is a predominance of type-2 helper T cells (Th2) in atopic dermatitis. A higher number of cases would involve the increased uptake of therapeutics, thereby increasing the growth of the market.

The global atopic dermatitis market is heavily fragmented, with numerous generic products at relatively low prices. The patent expiry of marketed products such as Protopic and Elidel in the period 2012 2015 would allow the further entry of generic products at cheaper prices, reducing market growth as well as the market size.

GlobalData, the industry analysis specialist, has released its new report, Atopic Dermatitis – Pipeline Assessment and Market Forecasts to 2017. The report is an essential source of information and analysis on the global Atopic Dermatitis therapeutics market. The report identifies the key trends shaping and driving the global Atopic Dermatitis therapeutics market. The report also provides insights into the competitive landscape and the emerging players expected to significantly alter the positions of the existing market leaders. Most importantly, the report provides valuable insights into the pipeline products within the global Atopic Dermatitis sector.

For further details, please click or add the below link to your browser:
http://www.globaldata.com/reportstore/Report.aspx?ID=Atopic-Dermatitis-Drug-Pipeline-Analysis-and-Market-Forecasts-to-2016&ReportType=Industry_Report&coreindustry=Industry_Report&Title=Pharmaceuticals_and_Healthcare

Visit our report store: http://www.globaldata.com

For more details contact:
pressreleases@globaldata.com
North America: +1 646 395 5477
Europe: +44 207 753 4299
+44 1204 543 533
Asia Pacific: +91 40 6616 6782

GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage including oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries

Find More Atopic Dermatitis Treatment Articles